The Kable

The Kable

Share this post

The Kable
The Kable
πŸ’‰ Sanofi looks to China; Gilead bets on immune checkpoints; Amgen punts $4 billion on autoimmune therapies
Copy link
Facebook
Email
Notes
More
Friday Kable

πŸ’‰ Sanofi looks to China; Gilead bets on immune checkpoints; Amgen punts $4 billion on autoimmune therapies

Africans live longer lives now

Vinod's avatar
Vinod
Aug 05, 2022
βˆ™ Paid
1

Share this post

The Kable
The Kable
πŸ’‰ Sanofi looks to China; Gilead bets on immune checkpoints; Amgen punts $4 billion on autoimmune therapies
Copy link
Facebook
Email
Notes
More
Share

Hello and welcome back to The Kable. This has been quite the week, eh? Deals; disease; drugs. And our very first long read by Nikita Mehta on the worrying similarities between the early global response to monkeypox and Covid.

In today’s Kable: Life expectancy goes up in Africa; Iran exports vaccines to Venezuela; Brazil uses virtual reality to separate …

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
Β© 2025 The Kable
Privacy βˆ™ Terms βˆ™ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More